Dual checkpoint inhibitor-associated eosinophilic enteritis

BACKGROUND: Eosinophilia has been reported as a rare, new biological effect of immune checkpoint inhibition that may be associated with improved treatment response and the development of immune-related adverse events. CASE PRESENTATION: We report a case of dual checkpoint inhibitor-associated hypere...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, J., Lagana, S. M., Saenger, Y. M., Carvajal, R. D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6858706/
https://www.ncbi.nlm.nih.gov/pubmed/31730503
http://dx.doi.org/10.1186/s40425-019-0743-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6858706/
https://www.ncbi.nlm.nih.gov/pubmed/31730503
http://dx.doi.org/10.1186/s40425-019-0743-5

Ejemplares similares